Jack Alpert
Neurology · Houston, TXNPI 1346209327
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.1% of the total across 186 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,582 and has fallen 92.9% since, to $182 in 2022.
Across 186 payments — averaging $17.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$533
- Sunovion Pharmaceuticals Inc.$410
- Biogen$263
- AstraZeneca$189
- Teva Pharmaceuticals USA, Inc.$183
- Acorda Therapeutics, Inc$177
- plus $2K from 23 others
What the payments were for
- Speaking & faculty fees$1775%
- Food & beverage$3,05793%
- Education$481%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 35 | $533 |
| Sunovion Pharmaceuticals Inc. | 32 | $410 |
| Biogen | 18 | $263 |
| AstraZeneca | 9 | $189 |
| Teva Pharmaceuticals USA, Inc. | 9 | $183 |
| Acorda Therapeutics, Inc | 8 | $177 |
| EMD Serono, Inc. | 8 | $171 |
| UCB, Inc. | 6 | $155 |
| GE HealthCare | 4 | $133 |
| Sanofi | 6 | $121 |
| Lilly USA, LLC | 7 | $121 |
| Adamas Pharmaceuticals, Inc. | 5 | $121 |
| Grifols USA, LLC | 8 | $117 |
| Neurocrine Biosciences, Inc. | 5 | $104 |
| Acadia Pharmaceuticals Inc | 2 | $51 |
| Assertio Therapeutics, Inc. | 2 | $45 |
| Upsher-smith Laboratories LLC | 3 | $43 |
| SK Life Science, Inc. | 2 | $43 |
| Bausch Health US, LLC | 2 | $40 |
| Eisai Inc. | 2 | $39 |
| Amneal Pharmaceuticals LLC | 3 | $39 |
| Promius Pharma LLC | 2 | $34 |
| Avanir Pharmaceuticals, Inc. | 2 | $30 |
| Amgen | 1 | $27 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Tanabe Pharma America, Inc. | 1 | $20 |
| Harmony Biosciences LLC | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| GSK | 1 | $15 |
How this compares
$3,283 in reported general payments places this provider in the 55th percentile of 1,246 neurology providers in Texas.
Other neurology in Houston
- William OndoHouston$1.4M
- Pankaj SatijaHouston$1.1M
- Annette HowardHouston$826K
- Randolph EvansHouston$493K
- Leorah FreemanHouston$401K
- Mazen DimachkieHouston$388K
- Zsila SadighiHouston$361K
- Joseph JankovicHouston$323K
- Raja MehannaHouston$300K
- Eddie PattonHouston$299K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.